Bal Pharma (NSE:BALPHARMA) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BALPHARMA Bal Pharma Ltd NSE:BALPHARMA
68 GF Score
Price ₹95.38
GF Value ₹103.43
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Bal Pharma Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

NSE:BALPHARMA
68GF Score
Bal Pharma Ltd NSE:BALPHARMA
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bal Pharma (NSE:BALPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Bal Pharma stock appears to be undervalued. The current stock price of ₹95.38 is trading 7.8% below its estimated GF Value™ of ₹103.43. GuruFocus considers Bal Pharma to be Fairly Valued.

Key valuation signals for NSE:BALPHARMA:

  • Dividends Received:
  • GF Value™: ₹103.43 vs. price of ₹95.38 (7.8% below fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the NSE:BALPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bal Pharma Business Description

Other Exchanges 524824:India
Address 10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives.
68GF Score

Get the complete analysis for NSE:BALPHARMA

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹95.38
Price
₹103.43
GF Value